APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-helminthic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Anti-helminthic Drugs Industry Research Report 2026

27 December 2025135 pages

Choose your research edition.

Industry ResearchAnti-helminthic Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-helminthic Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-helminthic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-helminthic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-helminthic Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-helminthic Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Anti-helminthic Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Anti-helminthic Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Anti-helminthic Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Anti-helminthic Drugs Market by Company

Anhui Shengying Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Chengdu Hengda Pharmaceutical Co., Ltd.

Diao Group Chengdu Pharmaceutical Co., Ltd.

Fujian Dongrui Pharmaceutical Co., Ltd.

Guilin Nanyao Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Jiaozuo Furuitang Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical Factory Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shanghai Tengrui Pharmaceutical Co., Ltd.

Shaoxing Minsheng Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Anti-helminthic Drugs Segment by Type

Pyrantel Pamoate

Piperazine

Mimbendazole

Praziquantel

Albendazole

Anti-helminthic Drugs Segment by Application

For Veterinary Use

For Human Use

Anti-helminthic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Anti-helminthic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Anti-helminthic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-helminthic Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Anti-helminthic Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Anti-helminthic Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Anti-helminthic Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Anti-helminthic Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Anti-helminthic Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Anti-helminthic Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Anti-helminthic Drugs, Product Type & Application Table 14. Global Anti-helminthic Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Anti-helminthic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 19. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 20. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 22. Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments Table 23. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 24. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 25. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 27. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments Table 28. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information Table 29. Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview Table 30. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 32. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments Table 33. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information Table 34. Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview Table 35. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 37. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments Table 38. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information Table 39. Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview Table 40. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 42. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments Table 43. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information Table 44. Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview Table 45. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 47. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments Table 48. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 49. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 50. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 52. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments Table 53. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 54. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 55. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 57. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments Table 58. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information Table 59. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview Table 60. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 62. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments Table 63. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 64. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 65. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 67. Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments Table 68. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 69. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 70. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 72. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments Table 73. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 74. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 75. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 77. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments Table 78. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information Table 79. Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview Table 80. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 82. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments Table 83. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information Table 84. Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview Table 85. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 87. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments Table 88. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 89. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 90. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 92. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments Table 93. Southwest Pharmaceutical Co., Ltd. Company Information Table 94. Southwest Pharmaceutical Co., Ltd. Business Overview Table 95. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 97. Southwest Pharmaceutical Co., Ltd. Recent Developments Table 98. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 99. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 100. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 102. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments Table 103. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 104. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 105. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 107. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments Table 108. Global Anti-helminthic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units) Table 110. Global Anti-helminthic Drugs Sales Market Share by Region (2021-2026) Table 111. Global Anti-helminthic Drugs Sales by Region (2027-2032) & (K Units) Table 112. Global Anti-helminthic Drugs Sales Market Share by Region (2027-2032) Table 113. Global Anti-helminthic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Anti-helminthic Drugs Revenue Market Share by Region (2021-2026) Table 115. Global Anti-helminthic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Anti-helminthic Drugs Revenue Market Share by Region (2027-2032) Table 117. North America Anti-helminthic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 119. North America Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 120. North America Anti-helminthic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Anti-helminthic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Anti-helminthic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 124. Europe Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 125. Europe Anti-helminthic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Anti-helminthic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Anti-helminthic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Anti-helminthic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Anti-helminthic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Anti-helminthic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 134. South America Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 135. South America Anti-helminthic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Anti-helminthic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Anti-helminthic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Anti-helminthic Drugs Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Anti-helminthic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Anti-helminthic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 143. Global Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 144. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2026) Table 145. Global Anti-helminthic Drugs Sales Market Share by Type (2027-2032) Table 146. Global Anti-helminthic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Anti-helminthic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2026) Table 149. Global Anti-helminthic Drugs Revenue Market Share by Type (2027-2032) Table 150. Global Anti-helminthic Drugs Price by Type (2021-2026) & (US$/Unit) Table 151. Global Anti-helminthic Drugs Price by Type (2027-2032) & (US$/Unit) Table 152. Global Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 153. Global Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 154. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2026) Table 155. Global Anti-helminthic Drugs Sales Market Share by Application (2027-2032) Table 156. Global Anti-helminthic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Anti-helminthic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2026) Table 159. Global Anti-helminthic Drugs Revenue Market Share by Application (2027-2032) Table 160. Global Anti-helminthic Drugs Price by Application (2021-2026) & (US$/Unit) Table 161. Global Anti-helminthic Drugs Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Anti-helminthic Drugs Distributors List Table 165. Anti-helminthic Drugs Customers List Table 166. Anti-helminthic Drugs Industry Trends Table 167. Anti-helminthic Drugs Industry Drivers Table 168. Anti-helminthic Drugs Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Anti-helminthic Drugs Product Image Figure 5. Global Anti-helminthic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Anti-helminthic Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Anti-helminthic Drugs Sales (2021-2032) & (K Units) Figure 8. Global Anti-helminthic Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Pyrantel Pamoate Product Image Figure 10. Piperazine Product Image Figure 11. Mimbendazole Product Image Figure 12. Praziquantel Product Image Figure 13. Albendazole Product Image Figure 14. For Veterinary Use Product Image Figure 15. For Human Use Product Image Figure 16. Global Anti-helminthic Drugs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Anti-helminthic Drugs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Anti-helminthic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Anti-helminthic Drugs Sales by Region in 2025 Figure 22. Global Anti-helminthic Drugs Revenue by Region in 2025 Figure 23. North America Anti-helminthic Drugs Market Size by Country in 2025 Figure 24. North America Anti-helminthic Drugs Sales Market Share by Country (2021-2032) Figure 25. North America Anti-helminthic Drugs Revenue Market Share by Country (2021-2032) Figure 26. United States Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Anti-helminthic Drugs Market Size by Country in 2025 Figure 30. Europe Anti-helminthic Drugs Sales Market Share by Country (2021-2032) Figure 31. Europe Anti-helminthic Drugs Revenue Market Share by Country (2021-2032) Figure 32. Germany Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Anti-helminthic Drugs Market Size by Country in 2025 Figure 43. Asia Pacific Anti-helminthic Drugs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Anti-helminthic Drugs Revenue Market Share by Country (2021-2032) Figure 45. China Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Anti-helminthic Drugs Market Size by Country in 2025 Figure 54. South America Anti-helminthic Drugs Sales Market Share by Country (2021-2032) Figure 55. South America Anti-helminthic Drugs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Anti-helminthic Drugs Market Size by Country in 2025 Figure 60. Middle East and Africa Anti-helminthic Drugs Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Anti-helminthic Drugs Revenue Market Share by Country (2021-2032) Figure 62. Egypt Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Anti-helminthic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032) Figure 68. Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032) Figure 69. Global Anti-helminthic Drugs Price (US$/Unit) by Type (2021-2032) Figure 70. Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032) Figure 71. Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032) Figure 72. Global Anti-helminthic Drugs Price (US$/Unit) by Application (2021-2032) Figure 73. Anti-helminthic Drugs Value Chain Figure 74. Anti-helminthic Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Anti-helminthic Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Pyrantel Pamoate
  • Piperazine
  • Mimbendazole
  • Praziquantel
  • Albendazole
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Chengdu Hengda Pharmaceutical Co., Ltd.
  • Diao Group Chengdu Pharmaceutical Co., Ltd.
  • Fujian Dongrui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shanghai Tengrui Pharmaceutical Co., Ltd.
  • Shaoxing Minsheng Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Anti-helminthic Drugs Market Size (2021-2032)
  4. 2.2.2 Global Anti-helminthic Drugs Sales (2021-2032)
  5. 2.2.3 Global Anti-helminthic Drugs Market Average Price (2021-2032)
  6. 2.3 Anti-helminthic Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pyrantel Pamoate
  9. 2.3.3 Piperazine
  10. 2.3.4 Mimbendazole
  11. 2.3.5 Praziquantel
  12. 2.3.6 Albendazole
  13. 2.4 Anti-helminthic Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 For Veterinary Use
  16. 2.4.3 For Human Use
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Anti-helminthic Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Anti-helminthic Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Anti-helminthic Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Anti-helminthic Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Anti-helminthic Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Anti-helminthic Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Anti-helminthic Drugs, Established Date
  9. 3.9 Global Anti-helminthic Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Anhui Shengying Pharmaceutical Co., Ltd.
  2. 4.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  6. 4.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Beijing Taiyang Pharmaceutical Co., Ltd.
  8. 4.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  12. 4.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Chengdu Hengda Pharmaceutical Co., Ltd.
  14. 4.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  18. 4.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
  20. 4.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  24. 4.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Fujian Dongrui Pharmaceutical Co., Ltd.
  26. 4.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  30. 4.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Guilin Nanyao Pharmaceutical Co., Ltd.
  32. 4.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  36. 4.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Hubei Ruihua Pharmaceutical Co., Ltd.
  38. 4.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  42. 4.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  44. 4.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  48. 4.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  50. 4.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  54. 4.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Nanjing Pharmaceutical Factory Co., Ltd.
  56. 4.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  57. 4.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  58. 4.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
  60. 4.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 4.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  62. 4.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  66. 4.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  68. 4.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  72. 4.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
  74. 4.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  78. 4.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
  80. 4.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  84. 4.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Sichuan Tiande Pharmaceutical Co., Ltd.
  86. 4.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  90. 4.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Southwest Pharmaceutical Co., Ltd.
  92. 4.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  96. 4.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
  98. 4.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  102. 4.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
  104. 4.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  108. 4.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
5 Global Anti-helminthic Drugs Market Scenario by Region
  1. 5.1 Global Anti-helminthic Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Anti-helminthic Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Anti-helminthic Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Anti-helminthic Drugs Sales by Region: 2027-2032
  5. 5.3 Global Anti-helminthic Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Anti-helminthic Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Anti-helminthic Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Anti-helminthic Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Anti-helminthic Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Anti-helminthic Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Anti-helminthic Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Anti-helminthic Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Anti-helminthic Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Anti-helminthic Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Anti-helminthic Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Anti-helminthic Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Anti-helminthic Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Anti-helminthic Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Anti-helminthic Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Anti-helminthic Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Anti-helminthic Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Anti-helminthic Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Anti-helminthic Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Anti-helminthic Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Anti-helminthic Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Anti-helminthic Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Anti-helminthic Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Anti-helminthic Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Anti-helminthic Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Anti-helminthic Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Anti-helminthic Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Anti-helminthic Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Anti-helminthic Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Anti-helminthic Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Anti-helminthic Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Anti-helminthic Drugs Value Chain Analysis
  2. 8.1.1 Anti-helminthic Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Anti-helminthic Drugs Production Mode & Process
  5. 8.2 Anti-helminthic Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Anti-helminthic Drugs Distributors
  8. 8.2.3 Anti-helminthic Drugs Customers
9 Global Anti-helminthic Drugs Analyzing Market Dynamics
  1. 9.1 Anti-helminthic Drugs Industry Trends
  2. 9.2 Anti-helminthic Drugs Industry Drivers
  3. 9.3 Anti-helminthic Drugs Industry Opportunities and Challenges
  4. 9.4 Anti-helminthic Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst